S&P 500
5,963.60
+0.1%
+5.22
DJI
42,792.07
+0.3%
+137.33
NASDAQ
19,215.46
+0.0%
+4.36
Bitcoin
105,368.00
+0.2%
+192.60
AAPL
$208.66
-1.2%
-$2.60
AMZN
$205.97
+0.2%
+$0.38
GOOG
$167.77
+0.2%
+$0.34
META
$640.00
-0.1%
-$0.34
MSFT
$458.29
+0.9%
+$4.02
NVDA
$135.42
+0.0%
+$0.02
TSLA
$341.81
-2.3%
-$8.17
Vivos Therapeutics (NASDAQ: VVOS)
$2.31
(-9.1%)
-$0.23
Price as of May 19, 2025, 10:34 a.m. ET
Vivos Therapeutics Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Vivos Therapeutics Company Info
Vivos Therapeutics, Inc. is a medical technology company which engages in the development and commercialization of treatment alternatives for patients with sleep disordered breathing (SDB). Its solutions are also offered for patients with mild-to-moderate obstructive sleep apnea (OSA). The company was founded by Gurdev Dave Singh, Susan McCullough, RaeAnn Byrnes, Todd Huntsman, and R. Kirk Huntsman on July 7, 2016 and is headquartered in Littleton, CO.
News & Analysis
No articles found.
Valuation
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.